The robust regeneration potential of fetal tissue suggests that developmental biology may help guide strategies for tissue regeneration in adults. Decreases in regenerative capacity post-utero and with increasing age are likely due to multiple factors, however one important contributor may be changes in the availability and functionality of stem cells responsible for mounting a reparative response to injury. The overall objectives of this Bioengineering Research Partnership are to characterize and quantitatively compare the relative regenerative capacity of stem cells isolated from two distinct stages of human development (fetal and adult) and assess the effectiveness of different strategies for delivering stem cells for bone regeneration. The central hypothesis governing this research is that augmenting the number of viable stem cells at the injury site and promoting their reparative phenotype will significantly enhance functional repair of bone defects and spine fusion in a developmental stage dependent manner. To test this hypothesis, the multidisciplinary team will integrate stem cell biology with tissue engineering principles and well-established, quantitative test bed models. The approach will employ customized gene array analysis to elucidate differential gene regulation pathways of stem cells derived from amniotic fluid and adult bone marrow at baseline and during osteogenic differentiation. Composite scaffold and nanofiber mesh biomaterials technologies will be evaluated for their ability to effectively deliver stem cells for segmental defect repair and spine fusion. Finally, a novel biomimetic coating technology will be investigated as a means to program delivered stem cells towards the osteogenic phenotype. The proposed research is unique in that there has been very little to no previous research on quantitatively comparing the regenerative capacity of different stem cell sources, particularly from distinct developmental stages. The expected outcome of these studies is the identification of an effective stem cell source and delivery protocol that may be rapidly translated into new therapeutic options for patients lacking adequate endogenous cell repair mechanisms.

Public Health Relevance

Injured or degenerated musculoskeletal tissues are the most common cause of long-term pain and disability world-wide, motivating efforts to develop new tissue regenerative therapies. Using novel cell delivery approaches, this project will quantitatively compare the regenerative capacity of two non-embryonic stem cell sources from different developmental stages (fetal and adult) in the clinically relevant settings of large bone defects and spine fusion.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
1R01AR056694-01A1
Application #
7731072
Study Section
Musculoskeletal Tissue Engineering Study Section (MTE)
Program Officer
Wang, Fei
Project Start
2009-09-09
Project End
2011-08-31
Budget Start
2009-09-09
Budget End
2010-08-31
Support Year
1
Fiscal Year
2009
Total Cost
$662,635
Indirect Cost
Name
Georgia Institute of Technology
Department
Engineering (All Types)
Type
Schools of Engineering
DUNS #
097394084
City
Atlanta
State
GA
Country
United States
Zip Code
30332
Allen, Ashley B; Gazit, Zulma; Su, Susan et al. (2014) In vivo bioluminescent tracking of mesenchymal stem cells within large hydrogel constructs. Tissue Eng Part C Methods 20:806-16
Priddy, Lauren B; Chaudhuri, Ovijit; Stevens, Hazel Y et al. (2014) Oxidized alginate hydrogels for bone morphogenetic protein-2 delivery in long bone defects. Acta Biomater 10:4390-9
Kimelman, Nadav Bleich; Kallai, Ilan; Sheyn, Dmitriy et al. (2013) Real-time bioluminescence functional imaging for monitoring tissue formation and regeneration. Methods Mol Biol 1048:181-93
Stoppato, Matteo; Stevens, Hazel Y; Carletti, Eleonora et al. (2013) Effects of silk fibroin fiber incorporation on mechanical properties, endothelial cell colonization and vascularization of PDLLA scaffolds. Biomaterials 34:4573-81
Diab, Tamim; Pritchard, Eleanor M; Uhrig, Brent A et al. (2012) A silk hydrogel-based delivery system of bone morphogenetic protein for the treatment of large bone defects. J Mech Behav Biomed Mater 11:123-31
Dosier, Christopher R; Erdman, Christopher P; Park, Jung Hwa et al. (2012) Resveratrol effect on osteogenic differentiation of rat and human adipose derived stem cells in a 3-D culture environment. J Mech Behav Biomed Mater 11:112-22
Johnson, Mela R; Boerckel, Joel D; Dupont, Kenneth M et al. (2011) Functional restoration of critically sized segmental defects with bone morphogenetic protein-2 and heparin treatment. Clin Orthop Relat Res 469:3111-7
Sheyn, Dmitriy; Kallai, Ilan; Tawackoli, Wafa et al. (2011) Gene-modified adult stem cells regenerate vertebral bone defect in a rat model. Mol Pharm 8:1592-601
Kimelman-Bleich, Nadav; Pelled, Gadi; Zilberman, Yoram et al. (2011) Targeted gene-and-host progenitor cell therapy for nonunion bone fracture repair. Mol Ther 19:53-9
Kolambkar, Yash M; Dupont, Kenneth M; Boerckel, Joel D et al. (2011) An alginate-based hybrid system for growth factor delivery in the functional repair of large bone defects. Biomaterials 32:65-74

Showing the most recent 10 out of 21 publications